NCT05983965 2026-04-17Study of Tazemetostat in Lymphoid MalignanciesUniversity of Alabama at BirminghamPhase 1 Terminated6 enrolled
NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn